Physician profile
Patrick Mccarty
NPI 1083052930
$20,998.01
in general payments reported to CMS, 2019-2025
11 companies · $819 in 2025
The $819 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,342 · 2021: $3,578 · 2022: $1,102 · 2023: $1,270 · 2024: $365 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,220 · Travel and Lodging: $200 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,220.44 |
| Travel and Lodging | $199.70 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,098.54 | 2019-2025 | Da Vinci Surgical System |
| Endogastric Solutions, INC | $877.38 | 2021-2024 | Esophyx |
| Boston Scientific Corporation | $836.73 | 2019-2021 | |
| Medtronic, INC. | $570.04 | 2021-2022 | |
| Davol INC. | $255.09 | 2020-2025 | Phasix Mesh |
| Acera Surgical, INC. | $120.96 | 2022 | |
| Lexington Medical, INC. | $95.74 | 2021 | |
| Conmed Corporation | $70.44 | 2023 | Airseal |
| Acell, INC. | $30.35 | 2020 | |
| Integra Lifesciences Corporation | $23.98 | 2024 | Integra, Surgimend, Omnigraft |
| Merck Sharp & Dohme LLC | $18.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mccarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.